Fever developed in a 56-year-old man with sarcoidosis and bronchial asthma, and influenza was diagnosed. He was given zanamivir on the day of diagnosis, but he suffered a bronchial asthma attack 4 days after the diagnosis of influenza, and pneumonia developed 7 days subsequently. He was then admitted to our hospital. A rapid antigen test was positive for influenza type A, and reverse-transcriptase polymerase chain reaction results were also positive for novel influenza A (H1N1). Chest computed tomography showed homogeneous ground-glass opacities in bilateral lung fields, and novel influenza A (H1N1) pneumonia was diagnosed. The patient was treated with oseltamivir and steroid therapy for the bronchial asthma attack; however, ground-glass opacities enlarged and became consolidated. The lower lobes of both lungs showed shrinkage and persistent volume loss. Improvement in the consolidation was accompanied by improvement in his respiratory condition. We report a case with an interesting radiological course.

Download full-text PDF

Source

Publication Analysis

Top Keywords

novel influenza
12
influenza h1n1
12
bronchial asthma
12
h1n1 pneumonia
8
asthma attack
8
ground-glass opacities
8
influenza
6
[case novel
4
pneumonia shrinkage
4
shrinkage pulmonary
4

Similar Publications

Programmable Stapling Peptide Based on Sulfonium as Universal Vaccine Adjuvants for Multiple Types of Vaccines.

Adv Sci (Weinh)

January 2025

State Key Laboratory of Chemical Oncogenomics, School of Chemical Biology and Biotechnology, Peking University Shenzhen Graduate School, Shenzhen, 518055, P. R. China.

Adjuvants are non-specific immune enhancers commonly used to improve the responsiveness and persistence of the immune system toward antigens. However, due to the undefined chemical structure, toxicity, non-biodegradability, and lack of design technology in many existing adjuvants, it remains difficult to achieve substantive breakthroughs in the adjuvant research field. Here, a novel adjuvant development strategy based on stapling peptides is reported to overcome this challenge.

View Article and Find Full Text PDF

Pathogen nucleic acid detection technology based on isothermal amplification and CRISPR/Cas12a system offers advantages in terms of high sensitivity, high specificity, and rapidity. However, this method has not been widely applied because of its shortcomings in utilizing conventional instruments, which cannot satisfy the requirements for Point of Care Testing (POCT), such as integration, convenience, and miniaturization. In this study, we developed an integrated lift-heater centrifugal microfluidic platform (Lift-CM) to automate the processes of isothermal amplification and CRISPR/Cas12a detection.

View Article and Find Full Text PDF

Introduction: Vaccines to prevent important infections involving, e.g. influenza viruses, severe acute respiratory syndrome-causing coronaviruses (e.

View Article and Find Full Text PDF

Fluorofurimazine, a novel NanoLuc substrate, enhances real-time tracking of influenza A virus infection without altering pathogenicity in mice.

Microbiol Spectr

January 2025

Department of Microbiology and Immunology, Frederick P. Whiddon College of Medicine, University of South Alabama, Mobile, Alabama, USA.

Unlabelled: Bioluminescence imaging (BLI) using engineered bioluminescent viruses has emerged as a powerful tool for real-time, noninvasive monitoring of viral replication in living animals. While traditional luciferase-based systems, such as firefly luciferase, have been widely used, the NanoLuc luciferase system offers distinct advantages, including its significantly smaller gene size, increased brightness, and independence from ATP as a cofactor, allowing for extracellular detection. However, the utility of NanoLuc has been limited by its traditional substrate, furimazine, which exhibits poor water solubility and potential cytotoxicity.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!